Genor Biopharma Holdings Limited (06998.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 1.70

From 52W high−65.88%

Volume130000.00

Market capHKD 2.77B

P/E (TTM)4.6x

P/S (TTM)0.7x

Div yield—

Key dataSep 18, 2026

Open

HKD 1.70

From 52W high

−65.88%

Volume

130000.00

Market cap

HKD 2.77B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.4x

P/E (TTM)

4.6x

RSI (14)

49.0

MomentumView details →

1D Return

+0.30%

YTD Return

−44.83%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

4.6x

EV/EBITDA

2.4x

EV/Sales

0.7x

P/S (TTM)

0.7x

P/B (TTM)

0.6x

ProfitabilityView details →

Gross Margin

62.60%

Net Margin

12.09%

EBITDA Margin

31.44%

ROE (TTM)

10.82%

ROA (TTM)

7.07%

Asset Turnover

0.56x

GrowthView details →

Revenue YoY

+28.07%

EPS YoY

+675.25%

FCF YoY

+1329.47%

Revenue CAGR 3Y

+426.09%

EPS CAGR 3Y

−71.95%

EBITDA YoY

+26.15%

MomentumView details →

1D Return

+0.30%

YTD Return

−44.83%

1Y Return

−59.54%

RSI (14)

49.0

vs 50D SMA

−3.21%

vs 200D SMA

−31.86%

Capital & dividendView details →

Debt/Equity

0.30x

Current Ratio

1.00x

Quick Ratio

0.78x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−HKD 0.56

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

6.34B

Net Income (TTM)

939.60M

Op. CF (TTM)

—

Next earningsMar 31, 2027 →

Latest newsMore news →

No recent news for 06998.HK.

Similar companies

BioDlink International Company Limited01875.HK Beijing Luzhu Biotechnology Co., Ltd.02480.HK Soleno Therapeutics, Inc.SLNO Precigen, Inc.PGEN Immunome, Inc.IMNM NewAmsterdam Pharma Company N.V.NAMS Find similar companies →

Latest newsMore news →

No recent news for 06998.HK.